Carla G. Comanzo

Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines

María Paula Ceballos, Giulia Decándido, Ariel D. Quiroga et al. · Toxicology Letters · 2018 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +11

Sirtuin 1 and 2 inhibitors enhance the inhibitory effect of sorafenib in hepatocellular carcinoma cells

María Paula Ceballos, Antonella Angel, Carla Beatriz Delprato et al. · European Journal of Pharmacology · 2020 · 33 citations · Full text

Medicine, Oncology, Pharmacology +16

Hepatic carboxylesterase 3 (Ces3/Tgh) is downregulated in the early stages of liver cancer development in the rat

Ariel D. Quiroga, María Paula Ceballos, Juan P. Parody et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2016 · 17 citations · Full text

Medicine, Biochemistry, Oncology +11

IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice

Ariel D. Quiroga, Carla G. Comanzo, Francisco J. Heit Barbini et al. · Toxicology and Applied Pharmacology · 2019 · 14 citations · Full text

Life Sciences, Biochemistry, Pharmacology +9

Vitamin K2 supplementation blocks the beneficial effects of IFN-α-2b administered on the early stages of liver cancer development in rats

Marina C. Vera, Florencia Lorenzetti, Alvaro Lucci et al. · Nutrition · 2018 · 12 citations · Full text

Medicine, Nutritional Sciences, Pharmacology +8